Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
21.10.23 | AstraZeneca: IMFINZI (durvalumab) plus LYNPARZA (olaparib) reduced the risk of disease progression or death by 45% vs. chemotherapy in advanced or recurrent endometrial cancer | 806 | Business Wire | IMFINZI reduced the risk of disease progression or death by 29% vs. chemotherapy First Phase III trial to demonstrate clinical benefit of immunotherapy plus PARP inhibition in advanced or recurrent... ► Artikel lesen | |
21.10.23 | AnHeart Therapeutics' Investigational Medicine Taletrectinib Shrank Tumors in More Than 90 Percent of People With ROS1-Positive Non-Small Cell Lung Cancer Who Were ROS1 TKI Naïve in Global Pivotal TRUST-II Trial | 558 | Business Wire | Taletrectinib also shrank tumors in 57 percent of people with ROS1-positive NSCLC who had previously been treated with a ROS1 TKI in the trial Taletrectinib continues to be generally well tolerated... ► Artikel lesen | |
21.10.23 | Aviapartner Extends Footprint Through Joint Venture With South Africa | 517 | Business Wire | Aviapartner, leading Airport Ground Services group in Europe, enters a Joint Venture with Colossal to serve airlines and passengers in South Africa. With this partnership, the Belgium headquartered... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 1.740 |
EVOTEC | 1.396 |
TUI | 1.087 |
NVIDIA | 903 |
PLUG POWER | 753 |
BAYER | 653 |
RHEINMETALL | 641 |
NEL | 637 |
SIEMENS ENERGY | 624 |
BARRICK GOLD | 505 |
RENK GROUP | 485 |
DEUTSCHE BANK | 477 |
AIXTRON SE | 466 |
AMC ENTERTAINMENT | 455 |
BYD | 448 |
MERCEDES-BENZ | 434 |
VOLKSWAGEN | 433 |
COMMERZBANK | 413 |
DEUTSCHE LUFTHANSA | 386 |
SUPER MICRO COMPUTER | 377 |
HEIDELBERGER DRUCK | 368 |
TESLA | 364 |
RWE | 329 |
ALLIANZ | 322 |
BASF | 306 |